首页 产品中心
  • Paclitaxel
  • 紫杉醇;NSC 125973;Taxol
  • 货号: abs810020
    CAS号: 33069-62-4
    分子式: C47H51NO14
    分子量: 853.91
    产品说明书
    分享:
    货号-规格 货期 价格 数量
    abs810020-5mg 现货 ¥263.00
    - +
    abs810020-10mg 现货 ¥491.00
    - +
    abs810020-25mg 现货 ¥630.00
    - +
    abs810020-50mg 现货 ¥840.00
    - +
    abs810020-100mg 现货 ¥1278.00
    - +
    大包装询价
    产品描述
    描述

    Paclitaxel (紫杉醇) 是微管聚合稳定剂,IC50是0.1 pM。Paclitaxel 是有丝分裂抑制剂。

    纯度
    >99 %
    储存/保存方法
    store at -20℃ for one year(Powder);
    in DMSO or others solvent store at 2-4℃ for two weeks, at -20℃ for six months.
    基本信息
    别名
    紫杉醇;NSC 125973;Taxol
    外观
    Lyophilized powder
    可溶性/溶解性
    DMSO:171 mg/mL (200.25 mM)

    Ethanol:18 mg/mL (21.07 mM)
    生物活性
    靶点
    Microtubule (human endothelial cells)
    In vitro(体外研究)
    Paclitaxel inhibits non-endothelial type human cells at 104 - to 105 -fold higher concentrations, with IC50 of 1 nM-10 nM. The selectivity of Paclitaxel inhibition of cell proliferation is also species specific, as mouse ECs are not sensitive to Paclitaxel at ultra low concentrations. Inhibition of human ECs by Paclitaxel at ultra low concentrations does not affect the cellular microtubule structure, and the treated cells do not show G2/M cell cycle arrest and apoptosis, suggesting a novel but as yet unidentified mechanism of action. In an in vitro angiogenesis assay, Paclitaxel at ultra low concentrations blocks human ECs from forming sprouts and tubes in the three-dimensional fibrin matrix. In the presence of SMF, the efficient concentration of Paclitaxel on K562 cells is decreased from 50 to 10 ng/mL. The cell cycle arrest effect of Paclitaxel with or without SMF on K562 cells is correlated with DNA damage. Paclitaxel alone causes a time-dependent inhibition of CDK1 in four cell lines including A549 cells, H358, H1395 cells and H1666 cells.
    In vivo(体内研究)
    The inhibition rations of Paclitaxel alone on BC-V and BC-ER tumors are 49.78% and 51.23%, respectively. Treatment of six cycles of 20 mg/kg Paclitaxel significantly reduces the percentages of Ki-67-positive cells to 20.4% in BC-V tumors and 25.1% in BC-ER tumors, respectively.
    参考文献
    参考文献
    [1] Wang J, et al. Anticancer Drugs. 2003, 14(1), 13-19.
    [2] Sun RG, et al. Gen Physiol Biophys. 2012, 31(1), 1-10.
    [3] Zhang XH, et al. Cancer Lett. 2012, 322(2), 213-222.
    [4] Chang J, et al. Breast Cancer Res Treat. 2012.
    温馨提示:本产品仅作科研实验使用,不支持临床等研究
        提示: 尊敬的客户您好,如果您对我们的产品有什么疑问或想要了解的,可以点击“我要提问”按钮填写您的疑问。
        提交不成功?请联系info@absin.cn。
        我要提问

    促销资讯 更多

      订购信息
      您可以从我们的授权经销商处购买absin产品或获得技术支持。若要查看您所在地区的经销商,请从以下的下拉列表中选择。
      GO
      • 0